scispace - formally typeset
Search or ask a question

Are miRNAs involved in the progression and metastasis of head and neck cancer? 


Best insight from top research papers

MicroRNAs (miRNAs) play a significant role in the progression and metastasis of head and neck cancer (HNC) . They have been shown to impact various characteristics of HNC, including angiogenesis, invasion, metastasis, cell cycle, proliferation, and apoptosis . miRNAs can control the expression of genes involved in HNC pathogenesis and signaling networks, such as the WNT/β-catenin pathway, PTEN/Akt/mTOR pathway, TGFβ, and KRAS mutations . Additionally, miRNAs can affect the response of HNC to treatments like radiation and chemotherapy . Studies have also demonstrated that circular RNAs (circRNAs), which primarily function through miRNA sponges, are involved in HNC metastasis . Alterations in the expression of specific miRNAs have been identified as potential biomarkers for the diagnosis, prognosis, and therapeutic targeting of HNC . Overall, miRNAs have emerged as important regulators of HNC progression and metastasis, offering potential avenues for improved diagnosis and treatment strategies.

Answers from top 5 papers

More filters
Papers (5)Insight
Yes, miRNAs are involved in the progression and metastasis of head and neck squamous cell carcinoma (HNSCC). The paper discusses the diagnostic and prognostic values of miRNAs in the recurrence and metastasis of HNSCC.
The paper suggests that miRNAs hsa-miR-17-5p, hsa-miR-140-5p, and hsa-miR-874-3p may work as important regulators of VEGFA, KRAS, and NFE2L2 signaling pathways in head and neck cancer, indicating their potential involvement in cancer progression and metastasis.
Yes, miRNA alterations correlate with the progression and metastasis of head and neck squamous cell carcinoma (HNSCC).
Yes, miRNAs are involved in the progression and metastasis of head and neck cancer. The paper mentions that circular RNAs (circRNAs) primarily function through miRNA sponges, indicating the regulatory relationship between circRNAs and HNC metastasis.
Yes, miRNAs are involved in the progression and metastasis of head and neck cancer. The paper states that miRNAs play a role in angiogenesis, invasion, metastasis, cell cycle, proliferation, and apoptosis, which are all characteristics associated with the progression and metastasis of head and neck cancer.

Related Questions

Can miRNAs be used to detect cancer at an early stage?5 answersMicroRNAs (miRNAs) have emerged as potential biomarkers for the early detection of cancer, including lung cancer and bladder cancer. In the context of lung cancer, miRNAs have been shown to be stable, abundant, and easily detectable in tumor tissues and body fluids, making them suitable for diagnosis and treatment. Studies have compared different statistical methods for identifying differentially expressed miRNAs (DE-miRNAs) in large datasets, and computational mathematics/statistics have been used to improve miRNA analysis and identify clinically applicable biomarkers for lung cancer. In the case of bladder cancer, a three-miRNA signature (miR-27b-3p, miR-381-3p, and miR-451a) has been constructed with high sensitivity and specificity for the early diagnosis of bladder cancer, suggesting the potential of miRNAs as non-invasive biomarkers. Overall, these findings suggest that miRNAs can be used to detect cancer at an early stage, providing opportunities for improved outcomes and non-invasive diagnostic approaches.
What is the impact of miRNA expression on glucose metabolism reprogramming in head and neck squamous cell carcinoma?5 answersMicroRNA (miRNA) expression has a significant impact on glucose metabolism reprogramming in head and neck squamous cell carcinoma (HNSCC). miR-9-1, which is hypermethylated in nasopharyngeal carcinoma (NPC), inhibits glycolytic metabolism by reducing lactate production, glucose uptake, and ATP generation. It directly targets hexokinase 2 (HK2), a key enzyme in glycolysis, leading to reduced HK2 protein levels. SIX1, overexpressed in HNSCC, upregulates glucose uptake and ATP production by upregulating GLUT3, a glucose transporter. miR-23a-3p targets SIX1 and suppresses glucose uptake and proliferation in HNSCC. These findings highlight the role of miRNA alterations in modulating glucose metabolism in HNSCC, providing potential therapeutic targets for this cancer type.
What is the current clinical implication of metabolism-related miRNAs in squamous cell carcinoma of the neck?5 answersMetabolism-related miRNAs in squamous cell carcinoma of the neck have important clinical implications. These miRNAs play a role in controlling proliferation, differentiation, apoptosis, metastasis, epithelial-mesenchymal transition, and immune responses in HNSCC. They are involved in metabolic reprogramming, which is necessary for tumor development and survival in an unfavorable tumor microenvironment. Additionally, miRNA-based subtypes have been identified in HNSCC, which are associated with different stages of epithelial cell differentiation and have implications for clinical outcomes. Furthermore, miRNA clusters have been found to be associated with differential mutation patterns in HNSCC, providing insights into the pathophysiology of the disease. These findings highlight the potential of metabolism-related miRNAs as biomarkers for diagnosis, prognosis, and treatment of squamous cell carcinoma of the neck.
What is the role of microRNAs in oesophageal adenocarcinoma?4 answersMicroRNAs (miRNAs) play a significant role in the pathogenesis of oesophageal adenocarcinoma (OAC). They are involved in various aspects of OAC, including carcinogenesis, progression, treatment, prognosis, and diagnosis. Dysregulated miRNAs have been found in both tissue and serum samples of OAC patients, suggesting their potential as diagnostic and prognostic biomarkers. Several miRNAs have been identified as upregulated or downregulated in OAC, and their expression profiles can discriminate between OAC and normal epithelium. Additionally, specific miRNAs have been associated with the risk of mortality after OAC diagnosis. The detection and quantification of miRNAs in OAC can be challenging due to their small size, but methods such as miRNA microarrays and quantitative real-time polymerase chain reaction (RT-qPCR) have been developed for this purpose. Overall, miRNAs have emerged as potential therapeutic targets and valuable tools for improving the diagnosis, prognosis, and prediction of therapeutic response in OAC.
How does miRNAs act on glucose metabolism in head and neck cancer?5 answersMicroRNAs (miRNAs) play a role in regulating glucose metabolism in head and neck cancer. miRNA-451 inhibits the phosphatidylinositol-3 kinase (PI3K)/Akt signaling pathway, which affects glycolysis by regulating the localization of the glucose transporter 1 (GLUT1). miR-451 is negatively regulated through the phosphorylation and inactivation of its direct transcriptional activator OCT1 by 5' AMP-activated protein kinase (AMPK), which is activated by glucose depletion-induced metabolic stress. In addition, miRNAs have been found to modulate the metabolic landscape in breast cancer, including the regulation of carbon metabolism and glycerophospholipid and N-Glycan metabolism. Although specific information on miRNA regulation of glucose metabolism in head and neck cancer is not provided in the abstracts, these findings suggest that miRNAs may play a role in modulating glucose metabolism in this type of cancer as well.
How is miRNA involved in anticancer therapy?4 answersMicroRNAs (miRNAs) play a crucial role in anticancer therapy. They can function as oncogenes or tumor suppressors, and their dysregulation is a hallmark of liver cancer. MiRNAs can be used as therapeutic targets to normalize their expression and inhibit cancer cell proliferation or increase sensitivity to chemotherapy. Small interfering RNAs (siRNAs) also have miRNA-like activity and can be used to silence disease-causing genes. The development of miRNA-based therapeutic strategies for hepatocellular carcinoma (HCC) is challenging due to the stability of the oligos and their delivery systems. Various delivery systems, including virus-based and non-viral systems, have been explored for miRNA delivery. In addition, actively targeting miRNA therapeutics to cancer cells using nano-conjugates or vesicles decorated with antibodies or ligands specific to HCC antigens or receptors can enhance efficacy and minimize damage to healthy tissue. Advances in the delivery of miRNAs have shown promise in cancer therapy. Furthermore, nano-carriers can improve the stability and delivery of miRNAs, enhancing their anticancer effects.

See what other people are reading

How can cancer pathways be targeted for therapy?
4 answers
Cancer pathways can be targeted for therapy through various approaches. One approach is to inhibit key DNA damage response (DDR) kinases, such as ATM, ATR, and DNA-PK, which play a role in DNA damage-induced checkpoint control and DSB repair. Another strategy is to target metabolic dysregulations in cancer cells, such as glucose uptake and aerobic glycolysis, which provide increased energy and metabolite requirements for tumor progression. Additionally, targeting pathway molecules that regulate cancer stem cells (CSCs) is another option for therapy. CSCs are a subpopulation of tumor cells with selective capacities for tumor initiation, self-renewal, metastasis, and unlimited growth. Signaling pathways like Notch, Wnt, Hedgehog, and the tumor microenvironment are involved in the maintenance and survival of CSCs, making them potential targets for therapy. Overall, these approaches provide opportunities for developing targeted therapies that selectively inhibit specific molecules or pathways involved in cancer growth and progression.
How can apoptosis be used as a targeted mechanism for cancer therapy?
5 answers
Apoptosis, the programmed cell death mechanism, can be used as a targeted mechanism for cancer therapy. It plays a crucial role in maintaining cellular balance and eliminating neoplastic cells. Dysregulation of apoptosis control can lead to cancer cell survival and progression. Therefore, targeting the apoptotic pathway has been extensively studied as a potential drug target in cancer treatment. Phytochemicals (PCs) and plant-based nanoparticles (NPs) have shown efficacy in inducing apoptosis in cancer cells. Additionally, understanding the apoptotic pathways and molecules involved in cancer cells can guide the development of targeted therapies. Various extracts and fractions from plants and marine species have been found to induce apoptosis and inhibit cancer cell growth. Furthermore, apoptotic signaling pathways and mechanisms, along with the interactions among proteins involved, are being explored for targeted therapeutics. Targeting apoptosis in cancer therapy requires a better understanding of the apoptotic process and the identification of potential targets for intervention.
What are the therapeutic targets of non-coding RNAs?
5 answers
Non-coding RNAs (ncRNAs) have emerged as potential therapeutic targets in various diseases, including cancer, neurodegenerative illnesses, and cardiovascular diseases. Long non-coding RNAs (lncRNAs) have been identified as major players in regulatory networks and have a wide range of druggable targets, making them attractive for therapeutic interventions. In non-small cell lung cancer (NSCLC), lncRNAs have been implicated in the development of drug resistance and radiation sensitivity, making them potential biomarkers and therapeutic targets. In atherosclerosis, targeting lncRNAs has been explored as a strategy to stabilize and prevent plaque rupture, a major cause of cardiovascular diseases. In Alzheimer's disease (AD), dysregulation of lncRNAs has been associated with AD pathogenesis, and they hold promise as novel biomarkers and therapeutic targets. Additionally, microRNAs (miRNAs) have been described as master regulators of cancer hallmarks and have shown promise as targets for drug development in cancer therapeutics.
What are the therapeutic targets of non-coding RNAs in cancer?
4 answers
Non-coding RNAs, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), have emerged as therapeutic targets in cancer. These non-coding RNAs play important roles in cancer biology, including cell differentiation, proliferation, survival, invasion, and metastasis. Experimental data suggest that cancer phenotypes can be modified by targeting miRNA expression, making miRNAs attractive tools for drug development in cancer therapeutics. In addition to miRNAs, lncRNAs have also gained importance as potential therapeutic targets for cancer therapy. Furthermore, circRNAs have been identified as regulators of Wnt/β-catenin signaling, which is involved in cancer progression. Targeting non-coding RNAs, such as miRNAs, lncRNAs, and circRNAs, holds promise for the development of novel anti-cancer drugs.
Pathobiology of nasopharyngeal cancer ?
5 answers
Nasopharyngeal carcinoma (NPC) is a malignant tumor that is common in southern China, especially in Guangdong, and often occurs in the head and neck. NPC is a genetic disease with diverse extent of intertumor and intratumor heterogeneity. It can be conceptualized as a multidimensional spatiotemporal "unity of ecology and evolution" pathological ecosystem. NPC is associated with heritable genes, exposure to carcinogenic substances, and Epstein-Barr virus (EBV) infection. The tumor microenvironment (TME) in NPC is heavily infiltrated with T-lymphocytes and other stromal cells, which support the growth of NPC cells and latent EBV infection. Understanding the molecular mechanisms of NPC can provide novel information for disease screening, prognosis, and precision cancer treatment. The histological morphology, etiology, and gene changes of non-squamous immunophenotype nasopharyngeal carcinoma (NSNPC) are similar to those of classical NPC. NSNPC belongs to undifferentiated type in non-keratinized squamous cell carcinoma and has a lower recurrence rate and earlier clinical stage compared to classical NPC.
What are phenolic compounds?
5 answers
Phenolic compounds are chemical substances found in plants that have aromatic rings and at least two hydroxyl groups. They have various pharmacological and nutritional properties, including antimicrobial, antioxidant, anti-inflammatory, and anti-cancer activities. Phenolic compounds are synthesized through the Phenylpropanoid biosynthetic pathway and accumulate in plants during normal and stress conditions. They play a crucial role in plant physiology, such as growth, development, and defense against environmental stress. Phenolic compounds are also utilized in the development of innovative food packaging materials with antimicrobial and antioxidant activities. They are naturally present in a wide range of foods and agricultural waste, making them suitable for enhancing the quality and shelf life of food products. The consumption of foods rich in phenolic compounds has been associated with various health benefits, including the prevention and treatment of chronic diseases.
What are the most promising new cancer treatments?
5 answers
Recent advances in cancer therapies have shown promising results in the treatment of various types of cancer. These include stem cell therapy, targeted therapy, ablation therapy, nanoparticles, natural antioxidants, radionics, chemodynamic therapy, sonodynamic therapy, and ferroptosis-based therapy. In the case of pancreatic ductal adenocarcinoma (PDAC), several recent modalities have shown promise in treating the disease, although the 5-year survival rate remains low. Chimeric antigen receptor (CAR) T cells have emerged as one of the most promising new cancer therapies, but researchers are also exploring the use of CAR NK cells and CAR macrophages as potential treatments for certain types of cancer. Cancer immunotherapy, including immune-based therapies, anti-angiogenesis therapies, and gene and antisense therapies, is another area showing great potential in the fight against cancer. In the case of head and neck squamous cell carcinoma (HNSCC), targeted therapies such as EGFR inhibitors and novel therapies targeting VEGF, PI3K/AKT/mTOR pathway, cell cycle regulation, HRAS, and DNA repair mechanisms are being investigated.
Are there any biomarkers of progression of gastric precancerous lesions to carcinoma?
4 answers
Biomarkers of progression from gastric precancerous lesions to carcinoma have been identified. Methylation levels of AMPH, PCDH10, RSPO2, SORCS3, and ZNF610 were found to predict progression of gastric lesions independent of the effect of duration of H. pylori infection, baseline diagnosis, gender of the patient, or scores for mononuclear leukocytes, polymorphonuclear leukocytes, or intraepithelial lymphocytes. Additionally, miRNAs, including miR-18a-5p, were found to be progressively deregulated in the multistep gastric carcinogenesis model and were predictors of outcome in gastric adenocarcinoma patients. These findings suggest that DNA methylation levels and miRNA expression could serve as biomarkers for the progression of gastric precancerous lesions to carcinoma.
What the effects of dysregulation of hippo pathway?
4 answers
Dysregulation of the Hippo pathway can have various effects. It has been implicated in the transformation, metastasis, and chemotherapeutic drug resistance in virus-related cancer, as well as in the pathogenesis of viral infection such as persistence. Misregulation of the Hippo pathway can lead to cancer, developmental defects, and metabolic imbalance. In gastric cancer and Helicobacter pylori-induced infection, dysregulation of the Hippo pathway has been observed, suggesting its role in the onset and progression of gastric cancer. Dysregulation of the Hippo pathway has also been associated with a wide range of diseases, including cancer, eye diseases, cardiac diseases, pulmonary diseases, renal diseases, hepatic diseases, and immune dysfunction. Furthermore, dysregulation of the Hippo pathway can cause abnormal genetic programs, leading to overgrowth phenotypes in organs.
Is hippo pathway can be a tumor supressor?
5 answers
The Hippo pathway has been recognized as a tumor suppressor signaling pathway that regulates cellular processes involved in tumorigenesis. Activation of the Hippo pathway can lead to the suppression of tumor growth and the inhibition of oncogenic factors such as YAP and TAZ. Tyrosine phosphorylation of the Hippo pathway tumor suppressor LATS1 by Src kinase has been identified as a mechanism of Hippo pathway regulation. Activation of the Hippo pathway through WNT5a signaling has also been shown to suppress tumor growth. Additionally, modulation of the Hippo pathway by various anti-cancer agents has been found to have anti-tumor effects in lung cancer. These findings suggest that the Hippo pathway can indeed function as a tumor suppressor pathway.
What are the latest studies looking at epigenetics and cancer?
5 answers
Recent studies have focused on the role of epigenetic modifications in cancer progression and treatment. Epigenetic changes, such as histone modification, DNA methylation, and non-coding RNA, have been shown to play a critical role in the development of therapeutic resistance in cancer. Targeting these epigenetic modifications with specific drugs, such as DNA methyltransferase inhibitors and histone deacetylase inhibitors, has the potential to reverse drug resistance and restore sensitivity to standard therapies. Additionally, the interplay between epigenetics and cancer immunology has been explored, with the aim of developing therapeutics that combine both approaches. The concept of the epigenetic landscape, which describes potential cellular fates and regulatory processes, has been applied to understand cancer etiology and the plasticity of cancerous states. Advances in single-cell analysis and molecular assays have enriched our understanding of the diversity of phenotypic states defined by epigenetic control. Overall, these studies contribute to our understanding of how epigenetic modifications influence cancer progression and provide insights for the development of targeted therapies.